Company: ZURA
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001104659-25-038042
Chunk: 61

Company: Zura Bio Ltd
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 61
---
1, 2025. (12) Consists of 501,444 Class A ordinary shares underlying options exercisable within 60 days of April 1, 2025. (13) Consists of (i) 100,000 Class A ordinary shares held of record by Mr. Ploos van Amstel and (ii) 84,300 Class A ordinary shares underlying options exercisable within 60 days of April 1, 2025. 35 TABLE OF CONTENTS (14) Consists of 82,809 Class A ordinary shares underlying options exercisable within 60 days of April 1, 2025. (15) Consists of 82,809 Class A ordinary shares underlying options exercisable within 60 days of April 1, 2025. (16) Consists of 82,809 Class A ordinary shares underlying options exercisable within 60 days of April 1, 2025. (17) Consists of 84,300 Class A ordinary shares underlying options exercisable within 60 days of April 1, 2025. (18) Dr. Becker is a biotechnology principal of Access Industries, Inc., an affiliate of AIM, and does not have voting or dispositive power over the shares held by AI Biotechnology. Dr. Becker disclaims beneficial ownership of the shares held by AI Biotechnology except for his pecuniary interest therein, which is in the form of an indirect profits interest. Delinquent Section 16(a) Reports Section 16(a) of the Exchange Act requires our directors and executive officers, and persons who own more than 10 percent of a registered class of the Company’s equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of common shares and other equity securities of the Company. Officers, directors and greater than 10 percent shareholders are required by SEC regulation to furnish us with copies of all Section 16(a) forms they file. To our knowledge, based on a review of the copies of such reports furnished to us and written representations that no other reports were required, during the fiscal year ended December 31, 2024, we believe all Section 16(a) filing requirements applicable to our officers, directors and greater than 10 percent beneficial owners were complied with, except for: one late Form 4 for one transaction by Mr. Ploos van Amstel that was not filed until May 23, 2024 and one late Form 4 for one